title: Reply: limits of Mendelian randomization analyses in selection of secretory phospholipase A2-IIA as a valid therapeutic target for prevention of cardiovascular disease.
authors: Michael V
authors: MV
authors: Holmes
authors: Tabassome
authors: T
authors: Simon
authors: Holly J
authors: HJ
authors: Exeter
authors: Aroon D
authors: AD
authors: Hingorani
authors: Marc S
authors: MS
authors: Sabatine
authors: Ziad
authors: Z
authors: Mallat
authors: Juan P
authors: JP
authors: Casas
authors: Philippa J
authors: PJ
authors: Talmud
mesh_terms: D002318:Cardiovascular Diseases / Q000235:genetics*; D004247:DNA / Q000235:genetics*; D005786:Gene Expression Regulation; D006801:Humans; D057182:Mendelian Randomization Analysis / Q000379:methods*; D054497:Phospholipases A2, Secretory / Q000235:genetics*
chemical_list: D004247:DNA; D054497:Phospholipases A2, Secretory